Antileishmanial activity of diterpene acids in copaiba oil

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 1, 2013, Pages 59-64

  dos Santos, Adriana Oliveira ^a   Izumi, Erika ^a   Ueda Nakamura, Tânia ^b   Dias Filho, Benedito Prado ^a,b   da Veiga Júnior, Valdir Florêncio ^c   Vataru Nakamura, Celso ^a,b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

Copaifera; Diterpene acids; Leishmania amazonensis; Leishmaniasis

Indexed keywords

ANTIPROTOZOAL AGENT; BALSAM; COPAIBA BALSAM;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; IC 50; LEISHMANIA MEXICANA; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTIPROTOZOAL AGENTS; BALSAMS; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA MEXICANA; MICROSCOPY, ELECTRON, TRANSMISSION; PARASITIC SENSITIVITY TESTS;

COPAIFERA; COPAIFERA LANGSDORFFII; LEISHMANIA AMAZONENSIS; PROTOZOA;

EID: 84875466639     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762013000100010     Document Type: Article

References (20)

1. Aït-Oudhia K, Gazanion E, Vergnes B, Oury B, Sereno D 2011. Leishmania antimony resistance: what we know what we can learn from the field. Parasitol Res 109: 1225-1232.
2. Cruz AK, de Toledo JS, Falade M, Terrão MC, Kamchonwongpaisan S, Kyle DE, Uthaipibull C 2009. Current treatment and drug discovery against Leishmania spp and Plasmodium spp - a review. Curr Drug Targets 10: 178-192.
3. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Pinto AC, Henriques AT, Bou-habib DC, Saraiva BEM 2001. Antileishmanial activity of indoll alkaloid from Peschiera australis. Antimicrob Agents Chemother 45: 1349-1354.
4. Gelb MH, Hol WG 2002. Drugs to combat tropical protozoan parasites. Science 297: 343-344.
5. Izumi E, Ueda-Nakamura T, Veiga-Junior VF, Pinto AC, Nakamura CV 2012. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. J Med Chem 55: 2994-3001.
6. Kaye P, Scott P 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604-615.
7. Murray HW 2010. Treatment of visceral leishmaniasis in direction from Bihar State, India. Future Microbiol 5: 1301-1303.
8. Murray HW, Berman JD, Davies CR, Saravia NG 2005. Advances in leishmaniasis. Lancet 366: 1561-1577.
9. Rodrigues JCF, Bernardes CF, Visbal G, Urbina JA, Vercesi AE, Souza W 2007. Sterol methenyl tranferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist 158: 447-456.
10. Rosa MSS, Mendonça-Filho RR, Bizzo HR, Rodriguez IA, Soares RMA, Souto-Padrón T, Alviano CS, Lopes AHCS 2003. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47: 1895-1901.
11. Santa-Rita RM, Henriques-Pons A, Barbosa HS, Castro SL 2004. Effect of the lysophospholipid analogues edelfosine, ilmefosine and miltefosine against Leishmania amazonensis. J Antimicrob Chemother 54: 704-710.
12. Santos AO, Costa MA, Ueda-Nakamura T, Dias-Filho BP, Veiga-Júnior VF, Souza-Lima MM, Nakamura CV 2011. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. Exp Parasitol 129: 145-151.
13. Santos AO, Ueda-Nakamura T, Dias-Filho BP, Veiga-Jr VF, Nakamura CV 2012. Copaiba Oil: an alternative to development of new drugs against leishmaniasis. Evid Based Complement Alternat Med: 898419.
14. Santos AO, Ueda-Nakamura T, Dias-Filho BP, Veiga-Junior VF, Pinto AC, Nakamura, CV 2008. Effect of Brazilian copaiba oils on Leishmania amazonensis. J Ethnopharmacol 120: 204-208.
15. Santos AO, Veiga-Santos P, Ueda-Nakamura T, Dias-Filho BP, Sudatti DB, Bianco E M, Pereira RC, Nakamura CV 2010. Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis. Mar Drugs 8: 2733-2743.
16. Seifert K 2011. Structures, targets and recent approaches in anti-Leishmania drug discovery and development. Open Med Chem J 5: 31-39.
17. Tiuman TS, Santos AO, Ueda-Nakamura T, Dias-Filho BP, Nakamura CV 2011. Recent advances in leishmaniasis treatment. Int J Infect Dis 15: 525-532.
18. Ueda-Nakamura T, Attias M, Souza W 2001. Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study. Parasitol Res 87: 89-97.
19. Ueda-Nakamura T, Mendonça-Filho RR, Morgado-Diaz JA, Maza PK, Dias-Filho BP, Cortez DAG, Alviano DS, Rosa MS, Lopes AHCS, Alviano CS, Nakamura CV 2006. Antileishmanial activity of eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int 55: 99-105.
20. WHO - World Health Organization 2011. Urbanization: an increasing risk factor for leishmaniasis. Available from: who.int/wer>.